These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10816715)
1. [Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)]. Soubeyrand B; Boisnard F; Bruel M; Debois H; Delattre D; Gauthier A; Soum S; Thébault C Presse Med; 2000 Apr; 29(14):775-80. PubMed ID: 10816715 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Touzé E; Fourrier A; Rue-Fenouche C; Rondé-Oustau V; Jeantaud I; Bégaud B; Alpérovitch A Neuroepidemiology; 2002; 21(4):180-6. PubMed ID: 12065880 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine and risk of multiple sclerosis. DeStefano F; Verstraeten T; Chen RT Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacovigilance of hepatitis B vaccines]. Imbs JL; Decker N; Welsch M Bull Acad Natl Med; 2003; 187(8):1489-98; discussion 1498-500. PubMed ID: 15146580 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Lièvre M; ; Costagliola D; Evans S; Fourrier A; Imbs JL; Levy-Bruhl D; Merle L; Micallef J; Oger E Neurology; 2009 Oct; 73(17):1426-7. PubMed ID: 19858469 [No Abstract] [Full Text] [Related]
6. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S; Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Mikaeloff Y; Caridade G; Suissa S; Tardieu M Neurology; 2009 Mar; 72(10):873-80. PubMed ID: 18843097 [TBL] [Abstract][Full Text] [Related]
8. Vaccinations and risk of central nervous system demyelinating diseases in adults. DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT; Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period. Mouchet J; Bégaud B Vaccine; 2019 Apr; 37(15):2142-2148. PubMed ID: 30851966 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Hocine MN; Farrington CP; Touzé E; Whitaker HJ; Fourrier A; Moreau T; Tubert-Bitter P Vaccine; 2007 Aug; 25(31):5938-43. PubMed ID: 17597263 [TBL] [Abstract][Full Text] [Related]
11. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Halsey NA; Duclos P; Van Damme P; Margolis H Pediatr Infect Dis J; 1999 Jan; 18(1):23-4. PubMed ID: 9951975 [No Abstract] [Full Text] [Related]
13. Systemic adverse effects of hepatitis B vaccines are rare. Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143 [TBL] [Abstract][Full Text] [Related]
14. [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!]. Costagliola D Rev Epidemiol Sante Publique; 2008 Dec; 56(6):379-81. PubMed ID: 19019601 [No Abstract] [Full Text] [Related]
15. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. Demicheli V; Rivetti A; Di Pietrantonj C; Clements CJ; Jefferson T J Viral Hepat; 2003 Sep; 10(5):343-4. PubMed ID: 12969184 [No Abstract] [Full Text] [Related]
16. [The first episode of central nervous system demyelinization and hepatitis B virus vaccination]. Touzé E; Gout O; Verdier-Taillefer MH; Lyon-Caen O; Alpérovitch A Rev Neurol (Paris); 2000 Mar; 156(3):242-6. PubMed ID: 10740095 [TBL] [Abstract][Full Text] [Related]
17. Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production. Martínez-Sernández V; Figueiras A J Neurol; 2013 Aug; 260(8):1951-9. PubMed ID: 23086181 [TBL] [Abstract][Full Text] [Related]
18. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. Langer-Gould A; Qian L; Tartof SY; Brara SM; Jacobsen SJ; Beaber BE; Sy LS; Chao C; Hechter R; Tseng HF JAMA Neurol; 2014 Dec; 71(12):1506-13. PubMed ID: 25329096 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. Fourrier A; Bégaud B; Alpérovitch A; Verdier-Taillefer MH; Touzé E; Decker N; Imbs JL Br J Clin Pharmacol; 2001 May; 51(5):489-90. PubMed ID: 11422009 [No Abstract] [Full Text] [Related]
20. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Mikaeloff Y; Caridade G; Rossier M; Suissa S; Tardieu M Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1176-82. PubMed ID: 18056563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]